Lewis rats immunized with guinea pig myelin basic protein residues 68-86 develop acute experimental autoimmune encephalomyelitis and recover. The predominant T cell receptor expressed by the encephalitogenic T cells is TCRBV8S2. They persist in bone marrow many weeks after recovery. CD3 is down-regulated, but N 90% express CD4. They fail to proliferate to GPMBP68-86 unless a nitric oxide synthase inhibitor is added to the cultures. Perhaps these are memory T cells that are maintained in a suppressed state in BM by a nitric oxide-dependent mechanism.
Introduction
The Lewis rat is highly susceptible to experimental autoimmune encephalomyelitis (EAE), developing hind limb paralysis when immunized with 10-20 µg of guinea pig myelin basic protein (GPMBP) emulsified in Freund's complete adjuvant (CFA) (reviewed in Swanborg, 2001) . Paralysis develops within 10-14 days.
The dominant encephalitogenic GPMBP epitope for Lewis rats consists of residues 68-86 (YGSLPQKSQRSQDENPV (Hashim, 1977; Mannie et al., 1985) , and the predominant encephalitogenic T cell population induced in response to this peptide, expresses TCRBV8S2 in the T cell receptor (Burns et al., 1989; Chluba et al., 1989; Tsuchida et al., 1993) . Monoclonal antibodies (mAb) specific for TCRBV8S2 are available, and are useful for tracking the encephalitogenic T cells in situ. Although it is improbable that all TCRBV8S2 T cells are encephalitogenic, when used in conjunction with other tests, e.g., proliferation in vitro to GPMBP68-86, the finding is consistent with the conclusion that a subset of TCRBV8S2 T cells respond to the encephalitogenic antigen.
By day 18 post-immunization most rats have recovered, and are resistant to subsequent attempts to re-induce EAE with MBP or GPMBP68-86 (Willenborg, 1979) . However, T cells isolated from recovered Lewis rats are reactive in vitro with the immunizing antigen, as reflected by proliferative responses and secretion of IFN-γ when stimulated with MBP, and can also adoptively transfer EAE to Lewis recipients after short-term culture with MBP (Holda et al., 1980; Hinrichs et al., 1981) . These findings indicate that recovered Lewis rats harbor T cells with the potential to induce EAE, but that these autoreactive cells are maintained in a quiescent state. We, and others, have reported that this state of remission is associated with the appearance of T regulatory (Treg) (Adda et al., 1977; Welch et al., 1980; recently reviewed in O'Connor and Anderton, 2008) and inhibitory natural killer (NK) cells (Zhang et al., 1997; Matsumoto et al., 1998) .
Previous evidence from our laboratory revealed the existence of a subpopulation of bone marrow (BM)-derived NK cells that inhibits proliferation of naïve rat T cells to Con A and PMA/ionomycin (Trivedi et al., 2005; Kheradmand et al., 2008) , and of MBP-primed T cells to MBP (Smeltz et al., 1999; Wolf and Swanborg, 2001) . These NK cells express the NKR-P1A dim CD3 − phenotype, and function in a contact-dependent fashion to inhibit T cell proliferation via upregulation of the cell cycle inhibitor, p21, resulting in a G 0 /G 1 cell cycle arrest (Trivedi et al., 2005) . Concomitant with inhibition of T cell proliferation, these NKR-P1A dim NK cells downregulate CD3 expression by the T cells. Moreover, the nitric oxide synthase inhibitor, N G -monomethyl-arginine acetate (MMA), abrogates inhibition of T cell proliferation (Kheradmand et al., 2008) . This is consistent with the report that inhibition of nitric oxide synthase in Lewis rats that have recovered from acute EAE results in chronicrelapsing disease, which suggests that NO regulates this autoimmune disease (O'Brien et al., 2001 ). It has previously been reported that bone marrow is a major reservoir for memory CD8 cells (Becker et al., 2005; Mazo et al., 2005) . Since Lewis rats that have recovered from EAE harbor T cells that can be activated to transfer disease (Holda et al., 1980; Hinrichs et al., 1981) , it is conceivable that these cells may migrate to the bone Journal of Neuroimmunology 209 (2009) 26-32 
